Diagnostic and Screening Tests: Validity and Reliability
17 Pages1595 Words87 Views
Added on 2021-04-17
Diagnostic and Screening Tests: Validity and Reliability
Added on 2021-04-17
ShareRelated Documents
Running head: HCS630 FINAL PROJECT
HCS630 Final Project
Name of Student
Name of University
Author Note
HCS630 Final Project
Name of Student
Name of University
Author Note
1HCS630 FINAL PROJECT
Table of Contents
Attack Rate.................................................................................................................................2
1..............................................................................................................................................2
2..............................................................................................................................................2
3..............................................................................................................................................3
4..............................................................................................................................................3
5..............................................................................................................................................3
Morbidity Measures...................................................................................................................4
1..............................................................................................................................................4
2..............................................................................................................................................4
1..............................................................................................................................................5
2..............................................................................................................................................5
3..............................................................................................................................................6
4..............................................................................................................................................6
5..............................................................................................................................................6
YPLL..........................................................................................................................................6
1..............................................................................................................................................6
2..............................................................................................................................................7
Diagnostic and Screening Tests: Validity and Reliability.........................................................7
1..............................................................................................................................................9
2..............................................................................................................................................9
3..............................................................................................................................................9
Table of Contents
Attack Rate.................................................................................................................................2
1..............................................................................................................................................2
2..............................................................................................................................................2
3..............................................................................................................................................3
4..............................................................................................................................................3
5..............................................................................................................................................3
Morbidity Measures...................................................................................................................4
1..............................................................................................................................................4
2..............................................................................................................................................4
1..............................................................................................................................................5
2..............................................................................................................................................5
3..............................................................................................................................................6
4..............................................................................................................................................6
5..............................................................................................................................................6
YPLL..........................................................................................................................................6
1..............................................................................................................................................6
2..............................................................................................................................................7
Diagnostic and Screening Tests: Validity and Reliability.........................................................7
1..............................................................................................................................................9
2..............................................................................................................................................9
3..............................................................................................................................................9
2HCS630 FINAL PROJECT
4..............................................................................................................................................9
5..............................................................................................................................................9
6..............................................................................................................................................9
Infant Mortality Rates in US in 2011.........................................................................................9
1............................................................................................................................................10
2............................................................................................................................................10
3............................................................................................................................................10
Risk Assessment.......................................................................................................................11
Step 1: Relative risk.............................................................................................................12
1........................................................................................................................................12
Step 2: Odds Ratio...............................................................................................................12
1........................................................................................................................................12
2........................................................................................................................................13
Step 3: Attributable Risk, Percentage of Attributable Risk.................................................13
1........................................................................................................................................13
2........................................................................................................................................13
References................................................................................................................................14
4..............................................................................................................................................9
5..............................................................................................................................................9
6..............................................................................................................................................9
Infant Mortality Rates in US in 2011.........................................................................................9
1............................................................................................................................................10
2............................................................................................................................................10
3............................................................................................................................................10
Risk Assessment.......................................................................................................................11
Step 1: Relative risk.............................................................................................................12
1........................................................................................................................................12
Step 2: Odds Ratio...............................................................................................................12
1........................................................................................................................................12
2........................................................................................................................................13
Step 3: Attributable Risk, Percentage of Attributable Risk.................................................13
1........................................................................................................................................13
2........................................................................................................................................13
References................................................................................................................................14
3HCS630 FINAL PROJECT
Attack Rate
The attack rate is given by the formula (Ahrens et al., 2014),
Attack rate= number of new afflictions in the population under risk
size of population under risk
The number of attack for persons who ate either tuna salad or egg salad or neither or both is
given in the following table.
1.
The attack rate for people who ate only egg salad is given by,
number of sick persons who ate egg salad and did not eat tuna salad
number of people who ate egg salad and not tuna salad ×100 %= 25
50 ×100 %
¿50%
2.
The attack rate for people who ate only tuna salad is given by,
number of sick persons who ate tuna salad and did not eat egg salad
number of people who ate tuna salad and not egg salad ×100 %= 140
198 ×100 %
=70.70%
Attack Rate
The attack rate is given by the formula (Ahrens et al., 2014),
Attack rate= number of new afflictions in the population under risk
size of population under risk
The number of attack for persons who ate either tuna salad or egg salad or neither or both is
given in the following table.
1.
The attack rate for people who ate only egg salad is given by,
number of sick persons who ate egg salad and did not eat tuna salad
number of people who ate egg salad and not tuna salad ×100 %= 25
50 ×100 %
¿50%
2.
The attack rate for people who ate only tuna salad is given by,
number of sick persons who ate tuna salad and did not eat egg salad
number of people who ate tuna salad and not egg salad ×100 %= 140
198 ×100 %
=70.70%
End of preview
Want to access all the pages? Upload your documents or become a member.
Related Documents
Research Report on Epidemiologylg...
|5
|625
|35
The inference that the diseaselg...
|10
|1128
|38